SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-24-039304
Filing Date
2024-05-03
Accepted
2024-05-03 06:07:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL MATERIALS ea0204165-03.htm DEFA14A 40516
  Complete submission text file 0001213900-24-039304.txt   41663
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39138 | Film No.: 24910678
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)